BIOFILCHEM2026-08-26BIOFILCHEM2026-08-262026-08-26RelatedPartyTransactionDomain1BIOFILCHEM2026-08-262026-08-26ResolutionOrAgendaDomain1BIOFILCHEM2026-08-26ResolutionOrAgendaDomain1BIOFILCHEM2026-08-262026-08-26ResolutionOrAgendaDomain2BIOFILCHEM2026-08-26ResolutionOrAgendaDomain2BIOFILCHEM2026-08-262026-08-26ResolutionOrAgendaDomain3BIOFILCHEM2026-08-26ResolutionOrAgendaDomain3BIOFILCHEM2026-08-262026-08-26ResolutionOrAgendaDomain4BIOFILCHEM2026-08-26ResolutionOrAgendaDomain4iso4217:INRxbrli:pureBIOFILCHEMBIOFIL CHEMICALS & PHARMACEUTICALS LIMITEDNew2026-08-2616:29:002026-08-26Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)41Wednesday2026-09-2315:00:00Indore4BIOFIL CHEMICALS & PHARMACEUTICALS LIMITEDCyano Pharma Private LimitedMr. Ketan Shah, Chairman and Managing Director of the Company and Shri Smitesh Shah Non-Executive Non-Independent Director alongwith their respective relatives are shareholders/members of Cyano Pharma Private LimitedAny other transactionPurchase and Sale of goods and Rendering of services (job work), and other similar business transactions including transfer of resources, services2000000002026-04-012027-09-30Aggregate value of up to 20 Crores to be entered for financial year 2026-27 and up to the date of 42nd Annual General MeetingOrdinary ResolutionAdoption of Financial StatementsTo consider and adopt the Audited Financial Statements of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2026.Ordinary ResolutionOthersOthersRetire by rotationTo appoint a Director in place of Mr. Smitesh Shah (DIN: 00326182) who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible offers himself for re-appointment.Special ResolutionOthersOthersContinuation of directorship as a Non-Executive Independent Director on attaining the age of 75 (seventy-five) years.Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company on attaining the age of 75 (seventy-five) years.Ordinary ResolutionRelated Party TransactionApproval of Material Related Party Transaction(s) with Cyano Pharma Private Limited.